An open-label, non-randomized study to evaluate the therapeutic efficacy artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uige provinces, Angola.
Phase of Trial: Phase IV
Latest Information Update: 30 Dec 2015
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Pharmacogenomic; Therapeutic Use
- 30 Dec 2015 New trial record